Jump to content

Talk:Lopinavir

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Coformulations

[edit]

Need to merge in details on the coformulations page. References for several statements in this text need to be found/information clarified. The information there is currently:

Kaletra® = lopinavir (for its HIV protease enzyme inhibition) with ritonavir included to boost serum levels of lopinavir through inhibition of CYP3A4, a liver enzyme that metabolizes many other substances. The FDA approved it September 15, 2000, making it the seventeenth approved antiretroviral drug. It is the first multi-drug capsule that contains a drug not available individually. It has been demonstrated to be extremely potent and is often used in 'salvage' therapy for patients with some level of drug resistance. Some studies have suggested Kaletra is potent enough to be used as monotherapy and is also suitable for once-daily dosing, although neither is currently recommended. Marketed by Abbott Laboratories, its patent will expire in the United States on 2016-06-26.

Espresso Addict 09:01, 28 August 2006 (UTC)[reply]